老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
VanEck Biotech ETF
234.14
-2.5806
-1.09%
盤後:
234.48
0.3406
+0.15%
19:30 EDT
成交量:
2,519
成交額:
59.20萬
市值:
4.93億
市盈率:
- -
高:
237.15
開:
236.66
低:
234.01
收:
236.72
52周最高:
244.35
52周最低:
160.91
股本:
210.65萬
流通股本:
210.65萬
量比:
0.72
換手率:
0.12%
股息:
0.95
股息率:
0.40%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
Assembly Biosciences有望獲得高達2.8億美元里程碑付款及美國境外特許權使用費
美股速递
·
09/09
Assembly Biosciences旗下Gs-1179預計2026年底前將推進至生殖器皰疹二期臨床試驗階段
美股速递
·
09/09
Assembly Biosciences:吉利德獨享HSV HPI項目臨床開發與商業化權利
美股速递
·
09/09
Assembly Biosciences行使與吉利德關於HSV解旋酶-引物酶抑制劑項目的美國利潤分成選擇權
美股速递
·
09/09
安進股價或創二十餘年來最大單日跌幅
投资观察
·
09/09
福泰製藥(VRTX)股票9月8日盤中下跌3.06%:投資者必看的核心信息
TradingKey中文
·
09/09
吉利德科學(GILD)股票9月8日盤中下跌3.26%:釋放什麼信號?
TradingKey中文
·
09/09
諾華公司一款降膽固醇藥物在臨床試驗中失敗,Royalty Pharma股價下跌
路透中文
·
09/09
安進(AMGN)股票9月8日盤中下跌8.33%:真相來了
TradingKey中文
·
09/08
BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華
路透中文
·
09/08
更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期
路透中文
·
09/08
安進股價下跌7%,創下自2025年6月以來最大單日跌幅。
智通财经
·
09/08
更正-安進與阿斯利康聯合研發的抗癌藥物組合在晚期臨床試驗中達到了主要生存目標
路透中文
·
09/08
安進Phase 3 Dellphi-305研究重大突破:總生存期獲益顯著優於度伐利尤單抗單藥治療
美股速递
·
09/08
Imdelltra®聯合Imfinzi®在一線廣泛期小細胞肺癌中展現里程碑式總生存期改善
美股速递
·
09/08
BMO下調安進及BioNTech評級至「與大市同步」
格隆汇
·
09/08
美股盤前|英特爾、甲骨文升逾4%;諾華重挫12%,IONIS下跌10%;阿斯麥新一代EUV光刻機獲台積電和三星使用承諾
老虎资讯综合
·
09/08
諾華試驗受挫且BMO下調評級,安進股價下跌
路透中文
·
09/08
盤前異動:安進、耐克、Bloom Energy 等個股受關注
投资观察
·
09/08
美股異動|安進盤前跌5.4%,諾華同靶點藥物III期臨床失敗,Lp(a)賽道遭重創
中金财经
·
09/08
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BBH/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":234.1394,"timestamp":1789761600000,"preClose":236.72,"halted":0,"volume":2519,"hourTrading":{"tag":"盘后","latestPrice":234.48,"preClose":234.1394,"latestTime":"19:30 EDT","volume":18,"amount":4208.8058,"timestamp":1789774205696,"change":0.3406,"changeRate":0.001455,"amplitude":0},"delay":0,"changeRate":-0.010901486988847601,"floatShares":2106503,"shares":2106503,"eps":0,"marketStatus":"休市中","change":-2.5806,"latestTime":"09-18 16:00:00 EDT","open":236.66,"high":237.145,"low":234.01,"amount":592022.03016,"amplitude":0.013243,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":236.72,"sharesOutstanding":1976503,"nav":236.56399,"aum":498322764.45,"dividendRate":0.004048,"bidAskSpread":0.001072,"preHourTrading":{"tag":"盘前","latestPrice":236.72,"preClose":236.72,"latestTime":"04:00 EDT","volume":1,"amount":236.72,"timestamp":1789718407582,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":234.48,"preClose":234.1394,"latestTime":"19:30 EDT","volume":18,"amount":4208.8058,"timestamp":1789774205696,"change":0.3406,"changeRate":0.001455,"amplitude":0},"volumeRatio":0.7249337757599275,"impliedVol":0.1845,"impliedVolPercentile":0.3347},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2106503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7249337757599275,"shares":2106503,"dividePrice":0.9478,"high":237.145,"amplitude":0.013243,"preClose":236.72,"low":234.01,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":234.1394,"eps":0,"divideRate":0.004048,"volume":2519,"delay":0,"ttmEps":0,"open":236.66,"prevYearClose":189.2649,"prevWeekClose":229.3922,"prevMonthClose":236.396,"prevQuarterClose":203.2373,"fiveDayClose":229.3922,"twentyDayClose":237.1125,"sixtyDayClose":194.9611},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1136308873","title":"Assembly Biosciences有望獲得高達2.8億美元里程碑付款及美國境外特許權使用費","url":"https://stock-news.laohu8.com/highlight/detail?id=1136308873","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136308873?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897732,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前披露,其在海外市场具备资格获取最高达2.8亿美元的里程碑款项,外加相应特许权使用费收入。据悉,这家生物科技企业所预期的资金流入将源自美国以外地区。对Assembly Biosciences而言,这笔潜在收入不仅反映其管线资产的外部合作价值,也可能为其后续研发投入提供坚实支撑。市场人士认为,此类非美国市场的收益结构有助于分散地域风险,增强公司财务韧性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LU2468319806.SGD","IE00BSNM7G36.USD","LU0109394709.USD","LU2087621335.USD","IE00BKVL7J92.USD","LU1037948897.HKD","TMED","BK4550","LU1674673691.USD","LU1839511570.USD","LU0965509101.SGD","LU1430594728.SGD","LU0882574055.USD","TBXU","IE00BZ1G4Q59.USD","BK4532","LU1057294990.SGD","LU0965509010.AUD","BMED","LU0965509283.SGD","GILD","LU1674673428.USD","MEDI","LU1571399168.USD","IE00B19Z3B42.SGD","SG9999015945.SGD","LU1023059063.AUD","LU0058720904.USD","IBB","IE00B3T34201.USD","LU1778281490.HKD","LU1934455863.HKD","LU0823416689.USD","LU2112291526.USD","SG9999015978.USD","BK4568","LU0114720955.EUR","LU1934455194.USD","IBBQ","LU2324357040.USD","BK4566","IE00B19Z3581.USD","LU1066051498.USD","LU2089984988.USD","LU1934455277.USD","SG9999015986.USD","LU1037948541.HKD","LU0861579265.USD","LU0234570918.USD","BBH","LU0965508806.USD","LU1066053197.SGD","LU1585245621.USD","LU2357627491.SGD","SG9999015952.SGD","ASMB","LU0320765992.SGD","LU1061106388.HKD","BK4583","LU0859254822.USD","LU0889565916.HKD","LU0289739699.SGD","BIB","BK4139","IE0002270589.USD","IE00B7SZLL34.SGD","BK4578","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154623157","title":"Assembly Biosciences旗下Gs-1179預計2026年底前將推進至生殖器皰疹二期臨床試驗階段","url":"https://stock-news.laohu8.com/highlight/detail?id=1154623157","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154623157?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:02","pubTimestamp":1788897731,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司日前宣布,其研发管线中的候选药物Gs-1179有望在2026年年底之前顺利迈入针对生殖器疱疹的二期临床试验阶段。生殖器疱疹作为一种常见的性传播感染疾病,全球患者群体庞大,对创新疗法的需求十分迫切。Assembly Biosciences正积极加速该药物的研发进程,以期尽早为患者带来新的治疗选择。业内分析人士指出,若Gs-1179能够顺利通过后续试验的严格考验,将可能重塑该适应症的市场格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LU2468319806.SGD","IE00BSNM7G36.USD","LU0109394709.USD","LU2087621335.USD","IE00BKVL7J92.USD","LU1037948897.HKD","TMED","BK4550","LU1674673691.USD","LU1839511570.USD","LU0965509101.SGD","LU1430594728.SGD","LU0882574055.USD","TBXU","IE00BZ1G4Q59.USD","BK4532","LU1057294990.SGD","LU0965509010.AUD","BMED","LU0965509283.SGD","GILD","LU1674673428.USD","MEDI","LU1571399168.USD","IE00B19Z3B42.SGD","SG9999015945.SGD","LU1023059063.AUD","LU0058720904.USD","IBB","IE00B3T34201.USD","LU1778281490.HKD","LU1934455863.HKD","LU0823416689.USD","LU2112291526.USD","SG9999015978.USD","BK4568","LU0114720955.EUR","LU1934455194.USD","IBBQ","LU2324357040.USD","BK4566","IE00B19Z3581.USD","LU1066051498.USD","LU2089984988.USD","LU1934455277.USD","SG9999015986.USD","LU1037948541.HKD","LU0861579265.USD","LU0234570918.USD","BBH","LU0965508806.USD","LU1066053197.SGD","LU1585245621.USD","LU2357627491.SGD","SG9999015952.SGD","ASMB","LU0320765992.SGD","LU1061106388.HKD","BK4583","LU0859254822.USD","LU0889565916.HKD","LU0289739699.SGD","BIB","BK4139","IE0002270589.USD","IE00B7SZLL34.SGD","BK4578","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115029168","title":"Assembly Biosciences:吉利德獨享HSV HPI項目臨床開發與商業化權利","url":"https://stock-news.laohu8.com/highlight/detail?id=1115029168","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115029168?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897702,"startTime":"0","endTime":"0","summary":"Assembly Biosciences宣布,吉利德科学已保留其HSV HPI项目的独家临床开发及商业化权利。这一决定标志着双方合作进一步深化,吉利德将全权主导该项目的后续推进与市场布局。对于Assembly Biosciences而言,此举不仅明确了合作伙伴的战略优先级,也为其自身聚焦其他管线资源提供了更大灵活性。业内观察人士指出,HSV HPI项目的独家授权,反映了吉利德在抗病毒治疗领域持续加码的雄心,同时也凸显了该类创新疗法在未被满足的医疗需求中所蕴含的巨大潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509101.SGD","IE0002270589.USD","GILD","BK4568","LU1674673428.USD","LU1571399168.USD","IE00B19Z3581.USD","BK4139","IE00B3T34201.USD","LU1066051498.USD","LU0058720904.USD","LU0823416689.USD","LU1778281490.HKD","LU0965509010.AUD","LU0114720955.EUR","LU1057294990.SGD","BMED","ASMB","LU0289739699.SGD","LU0320765992.SGD","LU1061106388.HKD","BK4566","LU1066053197.SGD","LU1674673691.USD","LU2357627491.SGD","LU2087621335.USD","LU2324357040.USD","BK4578","LU1934455863.HKD","IE00B7SZLL34.SGD","TMED","LU1934455277.USD","LU1037948541.HKD","IE00BSNM7G36.USD","BK4585","LU0109394709.USD","LU0965508806.USD","SG9999015978.USD","BIB","IBBQ","LU2468319806.SGD","BK4532","LU0882574055.USD","LU1037948897.HKD","IE00B19Z3B42.SGD","LU0861579265.USD","BK4588","LU0965509283.SGD","SG9999015986.USD","LU0122379950.USD","BK4550","LU1839511570.USD","MEDI","LU1585245621.USD","LU1023059063.AUD","LU1934455194.USD","LU2089984988.USD","SG9999015952.SGD","SG9999015945.SGD","IE00BKVL7J92.USD","LU1430594728.SGD","LU2112291526.USD","BK4583","IBB","LU0859254822.USD","TBXU","LU0234570918.USD","IE00BZ1G4Q59.USD","LU0889565916.HKD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179230759","title":"Assembly Biosciences行使與吉利德關於HSV解旋酶-引物酶抑制劑項目的美國利潤分成選擇權","url":"https://stock-news.laohu8.com/highlight/detail?id=1179230759","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179230759?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 04:01","pubTimestamp":1788897669,"startTime":"0","endTime":"0","summary":"Assembly Biosciences公司已正式行使与吉利德科学就HSV解旋酶-引物酶抑制剂项目达成的美国利润分成选择权。这一战略举措标志着双方合作进入新阶段,有望加速该抗病毒疗法的临床开发与商业化进程。通过行使该选择权,Assembly Biosciences将能够分享该药物在美国市场的未来收益,同时借助吉利德在抗病毒领域的深厚积累与市场渠道,共同推进这一潜在重磅药物的落地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","BK4532","BIB","BK4583","GILD","LU0114720955.EUR","LU1585245621.USD","BK4588","IBB","BMED","BK4585","IE00BSNM7G36.USD","LU1037948897.HKD","IBBQ","IE00BKVL7J92.USD","SG9999015952.SGD","LU1674673691.USD","BK4566","IE00B3T34201.USD","LU1023059063.AUD","LU0320765992.SGD","LU1778281490.HKD","LU1839511570.USD","LU2089984988.USD","LU1057294990.SGD","LU0289739699.SGD","LU1934455194.USD","BK4578","LU0965508806.USD","LU1934455863.HKD","LU2112291526.USD","LU0882574055.USD","LU0861579265.USD","LU0965509283.SGD","ASMB","LU0109394709.USD","SG9999015986.USD","SG9999015945.SGD","LU2468319806.SGD","IE00B19Z3581.USD","LU1037948541.HKD","TBXU","BK4550","LU0058720904.USD","LU2357627491.SGD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU0965509010.AUD","LU1061106388.HKD","IE00BZ1G4Q59.USD","LU1674673428.USD","LU0122379950.USD","LU0965509101.SGD","BBH","LU0859254822.USD","MEDI","LU2324357040.USD","BK4568","IE0002270589.USD","TMED","LU1934455277.USD","LU0889565916.HKD","LU1066051498.USD","LU2087621335.USD","LU0234570918.USD","LU1571399168.USD","LU1430594728.SGD","LU1066053197.SGD","SG9999015978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111756325","title":"安進股價或創二十餘年來最大單日跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=1111756325","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111756325?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 02:23","pubTimestamp":1788891793,"startTime":"0","endTime":"0","summary":"安进公司股价近期重挫逾9%,这一跌幅令这家生物技术巨头有望迎来自2000年10月以来最惨淡的单日表现。此番暴跌的导火索,源于诺华制药宣布其心脏病药物pelacarsen在降低心血管事件风险方面未能优于安慰剂,试验宣告失败。周二,礼来股价小幅下挫1.9%。安进的跌势因BMO资本市场的下调评级而进一步加剧,使其沦为标普500指数和纳斯达克100指数中的最大输家。","market":"us","thumbnail":"https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0289739699.SGD","BBH","LU0122379950.USD","IBB","PBE","LU1983299246.USD","AMGN","BK4566","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4585","BK4581","LU0889565916.HKD","04332","SG9999001440.SGD","BK4533","TBXU","IE00B2B36J28.USD","LU2112291526.USD","IE0009355771.USD","PJP","LU1023059063.AUD","LU2242652126.USD","LU2089984988.USD","BIB","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0868494617.USD","LU2468319806.SGD","BK4534","IBBQ","LU0058720904.USD","IE00BJT1NW94.SGD","BK4599","BK4139","LU1057294990.SGD","LU1571399168.USD","LU2242646821.SGD","LU0320765992.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374214","title":"福泰製藥(VRTX)股票9月8日盤中下跌3.06%:投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374214","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374214?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 02:16","pubTimestamp":1788891392,"startTime":"0","endTime":"0","summary":"• Vertex 股价在反弹至接近52周高点后遭遇波动与获利回吐。\n• 对 Crinetics 的收购整合要到2029年才能实现非GAAP增盈。\n• 技术指标显示 MACD 呈中性,RSI 呈中性,威廉指标(Williams %R)呈超卖状态。","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156640-market-movers-vrtx-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","LU2237438978.USD","PBE","IDNA","IE0002141913.USD","IE00B4R5TH58.HKD","LU2417539215.USD","IE00B19Z3581.USD","LU1093756325.SGD","IBBQ","LU1674673691.USD","LU1430594728.SGD","BIB","LU0889565916.HKD","IE0002270589.USD","IE00B2B36J28.USD","SG9999001176.SGD","BBH","LU1674673428.USD","BK4588","LU2089984988.USD","LU0079474960.USD","LU0417517546.SGD","LU1585245621.USD","BK4533","BK4532","IE0009355771.USD","LU0289739699.SGD","SG9999013999.USD","VRTX","BK4139","LU1069344957.HKD","LU1035775433.USD","SGXZ57979304.SGD","IE00B894F039.SGD","LU2362541513.USD","SG9999001176.USD","GNMX","IE00B19Z9Z06.USD","IBB","LU2362541273.HKD","TBXU","LU0432979614.USD","LU0234570918.USD","IE00BJT1NW94.SGD","LU0061475181.USD","BK4585","LU1093756168.USD","LU1778281490.HKD","LU2362540622.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666374570","title":"吉利德科學(GILD)股票9月8日盤中下跌3.26%:釋放什麼信號?","url":"https://stock-news.laohu8.com/highlight/detail?id=2666374570","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666374570?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 01:16","pubTimestamp":1788887780,"startTime":"0","endTime":"0","summary":"• 吉利德在经历了长达数月的持续上涨后,因获利回吐而出现回调。\n• 强劲的第二季度营收主要受其旗舰 HIV 和 Trodelvy 产品线的推动。\n• 分析师维持“买入”评级,平均目标价为 157.79 美元。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156554-market-movers-gild-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948541.HKD","IE00B7SZLL34.SGD","IBBQ","IE00B19Z3581.USD","MEDI","LU0122379950.USD","SG9999015952.SGD","LU1674673428.USD","LU1571399168.USD","BBH","IE00BKVL7J92.USD","BK4578","LU0109394709.USD","LU1674673691.USD","BK4532","LU0320765992.SGD","LU0965508806.USD","LU1430594728.SGD","LU0058720904.USD","IE00BZ1G4Q59.USD","BK4585","LU0965509101.SGD","LU1778281490.HKD","LU2112291526.USD","LU1839511570.USD","TBXU","SG9999015945.SGD","LU0289739699.SGD","BK4568","SG9999015986.USD","BIB","GILD","IE00B3T34201.USD","BMED","LU0859254822.USD","LU0114720955.EUR","LU1023059063.AUD","BK4583","SG9999015978.USD","LU0823416689.USD","LU2324357040.USD","LU2087621335.USD","IBB","IE00B19Z3B42.SGD","LU1934455277.USD","LU0861579265.USD","IE00BSNM7G36.USD","TMED","IE0002270589.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666371445","title":"諾華公司一款降膽固醇藥物在臨床試驗中失敗,Royalty Pharma股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2666371445","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666371445?lang=zh_tw&edition=fundamental","pubTime":"2026-09-09 00:41","pubTimestamp":1788885660,"startTime":"0","endTime":"0","summary":"——Royalty Pharma** RPRX重申“其2030年投资组合收入目标为47亿美元或更高”** 计入本交易日涨幅,该股今年以来累计上涨54.7%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4501DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","BK4533","IHE","LU2242652126.USD","BK4588","LU0320765992.SGD","TBXU","IBB","LU1061106388.HKD","IONS","BBH","BK4139","LU2468319806.SGD","PBE","LU0122379950.USD","BK4007","BK4534","IE00BJJMRZ35.SGD","LU0889565916.HKD","LU0058720904.USD","BK4585","BK4566","IBBQ","IE00B2B36J28.USD","RPRX","BIB","BK4599","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU2242646821.SGD","PJP","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU1023059063.AUD","LU1571399168.USD","AMGN","BK4581","IE0002141913.USD","LU2089984988.USD","LU0289739699.SGD","LU0868494617.USD","LU2112291526.USD","LU1983299246.USD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665376637","title":"安進(AMGN)股票9月8日盤中下跌8.33%:真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2665376637","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665376637?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 22:16","pubTimestamp":1788876978,"startTime":"0","endTime":"0","summary":"• 诺华 pelacarsen 试验失败,加大了安进竞品 olpasiran 的临床不确定性。\n• 出于对估值的担忧,BMO Capital 将安进的评级从“跑赢大盘”下调至“与大盘持平”。\n• 技术指标显示,安进的 RSI 为 40.256,威廉指标(Williams %R)为 97.857。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262156239-market-movers-amgn-20260908","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","BK4581","LU0889565916.HKD","LU1061106388.HKD","IE00BFTCPJ56.SGD","AMGN","IE0009355771.USD","BK4534","LU2242646821.SGD","LU1023059063.AUD","IE0002141913.USD","SG9999001440.SGD","LU0122379950.USD","IBBQ","BK4566","BK4585","BK4139","BIB","IBB","BK4599","LU2242652126.USD","LU1057294990.SGD","BK4588","IE00B2B36J28.USD","LU2089984988.USD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU2112291526.USD","LU2468319806.SGD","LU0109394709.USD","PBE","LU0320765992.SGD","BK4533","IE00BJT1NW94.SGD","LU0058720904.USD","LU1983299246.USD","BBH","LU0868494617.USD","TBXU","PJP","LU0289739699.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375206","title":"BUZZ——美國股市動態-Sigma Lithium、Shake Shack、諾華","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375206","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375206?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:58","pubTimestamp":1788875887,"startTime":"0","endTime":"0","summary":"BUZZ——美国股市动态-Sigma Lithium、Shake Shack、诺华工作区中用于查询单只股票行情的搜索字符串:STXBZ《今日展望》通讯:https://refini.tv/3LI4BU7《晨间新闻简报》:https://refini.tv/3dKUyB8路透9月8日-周二开盘时,华尔街主要股指涨跌不一,中东地区新一轮冲突推动油价升至7月下旬以来的最高水平,而市场正在等待本周晚些时候","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S45014M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2265009873.SGD","LU1878469433.USD","BK4120","IE0031619046.USD","GNOM","LU0950375773.USD","SGML","BK4585","LU2362541513.USD","LU0114720955.EUR","LU0878866978.SGD","ABM","LU1989764664.SGD","IONS","IONZ","IONL","RGTC","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU0882574055.USD","BK4535","IBAT","PHVS","LU2491050071.SGD","IE00B19Z4B17.USD","LU1057294990.SGD","LU2112291526.USD","IE00BLSP4239.USD","CTEC","LU2491049909.HKD","BK4534","BK4591","RGTX","LU0251132253.USD","SEI","HYDR","BK4007","LU2506951792.HKD","IE00B4R5TH58.HKD","LU0170899867.USD","RGTI","LU0234572021.USD","LU2362541273.HKD","BK4556","BEX","LU2506952097.USD","LU2506952170.USD","BSX","BK4581","BK4592","IE00BBT3K403.USD","RGTZ","BK4139","BK4602","IONQ","LU0985489474.SGD","BK4141","LU0444971666.USD","LU0211331839.USD","SGXZ57979304.SGD","BE","LU2468319806.SGD","RGYY","SHAK","LU0433182093.SGD","LU0985481810.HKD","SG9999013999.USD","TBXU","LU0068578508.USD","BK4102","BK4131","ILMN","LU0187121727.USD","IE0009354923.USD","LU0320765489.SGD","ICLN","BK4168","LU0353189763.USD","IE00BLSP4452.SGD","LU1791710582.SGD","BK4504","LU0238689110.USD","LU0823416689.USD","XES","UPGR","BK4082","VTWG","IE0002141913.USD","04332","PFE","CNRG","IE000M9KFDE8.USD","LU1153585028.USD","BIB","LU2506951875.HKD","ZAP","LU0138981039.USD","LU0077335932.USD","BK4550","LU1642822529.SGD","IE00B19Z3B42.SGD","LU0306807586.USD","LU1791710400.SGD","LU1066051498.USD","LU1883839398.USD","LU2244417387.USD","ROIV","IE0009355771.USD","LU1983299246.USD","LU0266013472.USD","LU1989764748.USD","LU0321505439.SGD","LU0289739699.SGD","LU0868494617.USD","LU0444973449.USD","QTUP","BK4541","WATS","BK4532","LU0011850046.USD","LU2506951958.HKD","LU0029874061.USD","BK4182","LU2357305700.SGD","LU2324357040.USD","SG9999002232.USD","WQTM","LU0122379950.USD","LU0320765992.SGD","OIH","LU0823414478.USD","LU1988902786.USD","LU2294711713.HKD","CHRW","LU0528227936.USD","SMOG","LU0321505868.SGD","LU0225771236.USD","SRPU","IE0002270589.USD","IE00BJJMRZ35.SGD","AMGN","BEG","IE00B66KJ199.SGD","LU2098885051.SGD","BK4209","LU1989772840.SGD","LU0823417653.USD","USNG","LU0306806265.USD","IBB","LU0267386448.USD","LU1720051108.HKD","LU1093756325.SGD","LU2242649171.HKD","LU1489326972.SGD","LU2264538146.SGD","LU2543165471.USD","NVS","SG9999001176.USD","LU0476273544.USD","SRPT","LU0225284248.USD","LU2089984988.USD","IE00BJT1NW94.SGD","IE0034235188.USD","CQTM","LU1291159041.SGD","SIMS","BK4597","IE00B19Z3581.USD","BK4567","IE00B2B36J28.USD","LU1894683264.USD","LU1061106388.HKD","LU1366192091.USD","LU2491050154.USD","SG9999002224.SGD","FRNW","LU2362540622.SGD","BK4505","LU0058720904.USD","LU2249611893.SGD","IE00B3T34201.USD","BK4121","LU0353189680.USD","PTH","BK4124","UNFI","BK4548","LU1023059063.AUD","NTLA","LU0432979614.USD","BK4179","LU1066053197.SGD","LU1571399168.USD","BK4170","IONC","LU1804176565.USD","BHVN","LU0957808578.USD","LU0225283273.USD","LU2357125470.USD","LU0208291251.USD","BEC","BK4533","SG9999011175.SGD","LU0048584097.USD","BBH","GNMX","IE00B7SZL793.SGD","LU1548497426.USD","IONX","LU2242646821.SGD","ALV","MEDX","LU0456855351.SGD","LU1064131342.USD","OZEM","RGTU","LU1303367103.USD","LU1720051017.SGD","BK4599","SG9999001176.SGD","DYN","PBE","BK4588","LU2596442595.SGD","PPH","PJP","LU1718418525.SGD","LU0345769631.USD","IOYY","SG9999003800.SGD","LU1093756168.USD","LU0070302665.USD","LU1989772923.USD","BEZ","BK4566","LU0109394709.USD","LU0823417737.USD","LU1894683348.USD","LU0128526141.USD","LU0823414551.USD","LU2087625088.SGD","LU1815336760.USD","LU1861558580.USD","LU1989771016.USD","VCLN","LU2242652126.USD","BK4578","EGGY","IBBQ","LU0889565916.HKD","LU1861559042.SGD","LU0345769128.USD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665251375","title":"更正-更新版 1-安進與阿斯利康的藥物組合在晚期研究中幫助肺癌患者延長了生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=2665251375","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665251375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:52","pubTimestamp":1788875520,"startTime":"0","endTime":"0","summary":"更新版 1-阿斯利康的联合用药方案在晚期研究中帮助肺癌患者延长了生存期全文补充了有关临床试验和背景的详细信息路透9月8日-阿斯利康AZN.L周二表示,其抗癌药物Imfinzi与安进的AMGN.O靶向免疫疗法Imdelltra联合使用,在一项晚期临床试验中显著提高了广泛期小细胞肺癌患者的总生存期。癌症治疗药物占阿斯利康销售额近一半;2025年,在该公司256.2亿美元的肿瘤产品收入中,Imfinzi贡献了60.6亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T45013T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029864427.USD","LU0823416689.USD","LU1989771016.USD","LU0969580561.USD","LU0058720904.USD","BK4588","LU1267930227.SGD","LU0211327993.USD","IE0009355771.USD","PBE","IBBQ","PJP","LU0557290698.USD","LU2237443382.USD","IE00B3T34201.USD","LU0997586432.USD","BBH","03165","LU1267930490.SGD","LU2237443622.USD","BK4585","LU2125909593.SGD","LU1153585028.USD","LU0171293334.USD","LU0211328371.USD","TBXU","LU0289739699.SGD","IBB","LU0784384876.USD","AZN.UK","LU2242646821.SGD","LU0792757196.USD","LU2468319806.SGD","LU0553294199.USD","LU2108987350.USD","BK4533","LU0887340254.USD","LU0158827948.USD","LU1273509221.SGD","LU1046234339.USD","LU2089284900.SGD","LU0889566641.SGD","LU0708994859.HKD","LU1196032939.SGD","LU0738911758.USD","LU1267930813.SGD","LU0211326755.USD","LU2279689827.SGD","BIB","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375527","title":"安進股價下跌7%,創下自2025年6月以來最大單日跌幅。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375527","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375527?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:30","pubTimestamp":1788874246,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBB","IE00BJT1NW94.SGD","LU1571399168.USD","LU0868494617.USD","BK4139","IBBQ","BK4599","PBE","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU2242652126.USD","BK4585","LU0320765992.SGD","LU2112291526.USD","IE0009355771.USD","LU0122379950.USD","BK4534","LU1061106388.HKD","LU2468319806.SGD","IE00B2B36J28.USD","LU0109394709.USD","LU0289739699.SGD","TBXU","BK4581","IE00B4R5TH58.HKD","LU0889565916.HKD","BK4566","IE0002141913.USD","LU0058720904.USD","LU1023059063.AUD","BK4588","LU1983299246.USD","LU2242646821.SGD","BIB","AMGN","IE00BJJMRZ35.SGD","LU2089984988.USD","BK4533","SG9999001440.SGD","BBH","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665732793","title":"更正-安進與阿斯利康聯合研發的抗癌藥物組合在晚期臨床試驗中達到了主要生存目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2665732793","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665732793?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:14","pubTimestamp":1788873260,"startTime":"0","endTime":"0","summary":"阿斯利康抗癌药物组合在晚期临床试验中达到主要生存目标路透9月8日-阿斯利康(AstraZeneca)AZN.L周二表示,其抗癌药物Imfinzi与安进(Amgen)的AMGN.O靶向免疫疗法Imdelltra联合使用,在一项晚期临床试验中,显著提高了广泛期小细胞肺癌一线治疗患者的总生存期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4S450114:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0868494617.USD","TBXU","LU0957799991.USD","BBH","LU1084165304.USD","PJP","LU2279689827.SGD","LU0969580561.USD","LU0526926950.USD","BIB","AZN.UK","BK4139","IBB","LU0029864427.USD","LU0545039389.USD","LU0058720904.USD","LU2242652126.USD","LU0920783379.SGD","LU0882574055.USD","PBE","IE0034235188.USD","LU0289739699.SGD","LU0077335932.USD","LU1863844749.USD","LU1046234339.USD","BK4599","LU0889566641.SGD","LU1487256676.USD","LU1880407132.USD","LU0997586515.USD","LU1829250122.USD","03165","LU1003076772.USD","AMGN","LU0661504455.SGD","LU0784383803.USD","LU0109394709.USD","LU1481599808.USD","LU0827474353.SGD","LU2091194634.USD","IBBQ","LU0122379950.USD","LU2355687059.USD","LU0203347892.USD","LU1023059063.AUD","LU2433249047.HKD","LU1170363599.USD","LU1923622614.USD","LU1061106388.HKD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115495471","title":"安進Phase 3 Dellphi-305研究重大突破:總生存期獲益顯著優於度伐利尤單抗單藥治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1115495471","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115495471?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:07","pubTimestamp":1788872830,"startTime":"0","endTime":"0","summary":"安进公司宣布,其Phase 3 Dellphi-305临床研究取得重大成果——与度伐利尤单抗单独用药相比,该疗法在总生存期上展现出显著且具有临床意义的改善。这一里程碑式的发现,无疑为肿瘤治疗领域注入了新的活力与希望。尽管完整的详细数据尚未全面披露,但安进方面表示,其临床意义及安全性特征将在即将召开的重大学术会议上进行详尽报告。安进公司并未止步于此。随着研发管线的持续推进,安进正逐步兑现其以创新疗法攻克严重疾病的承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2468319806.SGD","LU1061106388.HKD","LU1057294990.SGD","BK4581","PBE","TBXU","LU0320765992.SGD","IE0002141913.USD","LU1023059063.AUD","LU2242646821.SGD","IBBQ","IBB","BK4139","AMGN","LU0289739699.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4599","BK4534","LU2242652126.USD","LU0868494617.USD","PJP","BK4585","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0109394709.USD","BK4566","BK4533","IE00B4R5TH58.HKD","LU2112291526.USD","IE00BFTCPJ56.SGD","BIB","LU0058720904.USD","LU1571399168.USD","LU2089984988.USD","LU0122379950.USD","IE00BJT1NW94.SGD","BK4588","BBH","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109517247","title":"Imdelltra®聯合Imfinzi®在一線廣泛期小細胞肺癌中展現里程碑式總生存期改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1109517247","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109517247?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 21:04","pubTimestamp":1788872687,"startTime":"0","endTime":"0","summary":"Imdelltra®与Imfinzi®的联合疗法,于一线广泛期小细胞肺癌治疗领域,取得了具有划时代意义的总生存期提升。这一突破性进展,不仅为患者带来了新的曙光,也重塑了该领域的治疗格局。从数据层面观察,联合治疗方案的生存获益尤为显著,堪称里程碑式的成就。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","IE00B2B36J28.USD","BK4533","TBXU","BK4588","LU1061106388.HKD","BIB","LU0889565916.HKD","LU1571399168.USD","LU0289739699.SGD","IE0002141913.USD","IBB","PJP","BK4534","SG9999001440.SGD","BK4566","LU0122379950.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IBBQ","IE0009355771.USD","LU1983299246.USD","LU0058720904.USD","LU0109394709.USD","BK4581","LU0320765992.SGD","LU2242652126.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4599","LU0868494617.USD","LU2089984988.USD","PBE","AMGN","BK4139","LU2112291526.USD","IE00BJT1NW94.SGD","BBH","BK4585","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665387373","title":"BMO下調安進及BioNTech評級至「與大市同步」","url":"https://stock-news.laohu8.com/highlight/detail?id=2665387373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665387373?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:59","pubTimestamp":1788872377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","BK4534","BK4588","LU2468319806.SGD","LU0109394709.USD","IE0002141913.USD","PJP","IE00B2B36J28.USD","LU0122379950.USD","LU2242646821.SGD","TBXU","LU1057294990.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU1571399168.USD","LU1023059063.AUD","AMGN","LU0058720904.USD","IBB","LU2242652126.USD","PBE","LU2112291526.USD","IBBQ","BK4599","BK4566","LU2089984988.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","BBH","LU0289739699.SGD","LU0320765992.SGD","LU1061106388.HKD","BK4581","LU1983299246.USD","SG9999001440.SGD","BK4533","LU0889565916.HKD","IE00B4R5TH58.HKD","BIB","BK4139","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103332998","title":"美股盤前|英特爾、甲骨文升逾4%;諾華重挫12%,IONIS下跌10%;阿斯麥新一代EUV光刻機獲台積電和三星使用承諾","url":"https://stock-news.laohu8.com/highlight/detail?id=1103332998","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103332998?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 20:01","pubTimestamp":1788868860,"startTime":"0","endTime":"0","summary":"9月8日美元指数上升0.0364%,报98.96。03 要闻1. 三大芯片厂全面采购ASML最先进High NA EUV光刻机以扩产高端制程。ASML确认三星、台积电与英特尔已承诺在2028–2030年起量产使用High NA设备,并与ASML签订光罩尺寸升级合作协议,助力降低AI芯片制造成本。","market":"hk","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU0889566641.SGD","LU2471134879.HKD","BK4526","LU1917777945.USD","BK4612","BK4570","LU1150488218.USD","LU2491049909.HKD","LU1430597077.USD","SPRX","BK4575","IE00BHPRN162.USD","CWI","IYE","LU0432979614.USD","IBB","LU0949170772.SGD","IE00B7SZLL34.SGD","LU0823414478.USD","EGGY","BK4533","INYY","LU0082616367.USD","PJP","SG9999011175.SGD","LU0545039389.USD","LU0345770993.USD","DOG","LU0719512351.SGD","LU1211504680.USD","LU1323610961.USD","LU0211326755.USD","IE00B2Q91V27.USD","LU0158827781.USD","LU1162221912.USD","IE00BZ1G4Q59.USD","BK4588","FTXL","LU0912757837.SGD","PPH","LU2505996509.AUD","BK4538","IE00BMPRXN33.USD","LU2663582299.SGD","ORAC","LU1852331112.SGD","LU0077335932.USD","BK4138","ADVE","LU1548497426.USD","LU1674673428.USD","LU0417517546.SGD","XNTK","FENY","MEDX","BK4592","LU0642271901.SGD","ERX","LU0053666078.USD","LU0433182093.SGD","LU0476273544.USD","TEK","AIQ","03145","LU0878004406.USD","LU2326559502.SGD","LU0170899867.USD","IE000MB6IJN5.SGD","LU1935042991.SGD","LU2322448957.HKD","DRLL","LU1823568750.SGD","LU0795875169.SGD","LU0072462343.USD","LU1235294995.USD","LU0859254822.USD","LU2129689431.USD","CNEQ","BK4512","LU0109394709.USD","LU2211815571.USD","LU1720051017.SGD","IE00B3M56506.USD","LU1815336760.USD","SG9999002521.SGD","LU1061106388.HKD","FCG","LU1674673691.USD","LU1868837565.USD","BK4529","LU0208291251.USD","IEFA","LU2430703095.HKD","AVEM","SG9999004220.SGD","LU0957791311.USD","ORCZ","IE00BFXG0V08.USD","LU0965509283.SGD","LU0882747503.HKD","LU1201861249.SGD","LU2249611893.SGD","BK4550","LU0942090050.USD","LU0070217475.USD","LU2087625088.SGD","LU1093756168.USD","LU2471134952.CNY","SG9999014542.SGD","LU2237957902.USD","IE00BQXX3F31.USD","LU0058720904.USD","LU1732799900.SGD","DBEF","BK4599","LU0300736062.USD","LU0114720955.EUR","LU0496365809.HKD","LU0541502299.USD","TBXU","LU1988902786.USD","LU0225283273.USD","LU2148611432.USD","BK4147","LU0359202008.SGD","LU1778281490.HKD","LU1989764664.SGD","BK4532","LU0612318971.USD","BK4504","CGIC","IE00BQXX3C00.GBP","CHPS","LU0203345920.USD","LU2764263203.CNY","BK4503","BK4579","LU0788109394.HKD","LU1839511570.USD","DRIV","IE000M9KFDE8.USD","LU0353189763.USD","LU1623119135.USD","LU2271345857.HKD","LU2468319806.SGD","IE0031619046.USD","IE00B19Z3581.USD","LU1057294990.SGD","QQQA","LU0823038988.USD","BK4139","LU2298321311.HKD","IE00B775SV38.USD","LU0157215616.USD","LU2491050154.USD","LU0348723411.USD","LU0572940350.SGD","BK4201","LU2462611646.USD","UMMA","PXI","BK4007","ORCL","SGXZ99366536.SGD","LU0654597011.USD","BK4505","LU2746668461.USD","LU0861579265.USD","LU2999663052.SGD","LU1989772923.USD","BK4082","INTW","LU0310799852.SGD","LU0823421416.USD","LU0158827948.USD","LU2471134523.USD","FDTX","FFGX","LU1989764748.USD","LU0345769631.USD","LU0359201612.USD","LU0823434740.USD","LU0128526141.USD","BK4121","IFLR","ORCS",".DJI","ORCX","LU0289739699.SGD","SG9999002224.SGD","LU2242649171.HKD","LU2462591277.SGD","CHAT","BK4097","MEMX","LU2108987350.USD","LU2092937221.SGD","LU2764263039.SGD","LU0868494708.USD","LU1282649810.SGD","LU0130517989.USD","SMH","LU2505996681.GBP","BK4535","LU0345780950.USD","LU1093756325.SGD","LU1815333072.USD","LU2237443978.SGD","LU1037948541.HKD","LU1064131342.USD","VDE","BK4528","LU2471134796.USD","LU1642822529.SGD","LU2931357623.SGD","LU2764262908.HKD","BK4591","SG9999014559.SGD","LU2506952097.USD","SPTE","LU1861220033.SGD","LU0345774631.USD","RSPG","LU2028103732.USD","LU2498475776.HKD","IE00BKVL7J92.USD","GNMX","LU0320765992.SGD","BK7095","IE0034235303.USD","LU1934455194.USD","LU0203347892.USD","LU0122376428.USD","IE0009356076.USD","LU1571399168.USD","LU0648001328.SGD","LU2430703251.USD","IE000BZT7R73.USD","LU0868494617.USD","LU2357125470.USD","LU2324357040.USD","LU2347655156.SGD","LU0211328371.USD","IE00B3CCJ963.GBP","LU2430703178.SGD","LU0345774391.USD","LU2125154935.USD","LU1804176565.USD","LU0444971666.USD","CQTM","IE00BLSP4239.USD","LU1316542783.SGD","CHPX","LU2362541513.USD","LU0823417653.USD","INT","LU1066051498.USD","LU0314106906.USD","AVXC","LU0143551892.USD","LU1506573853.SGD","CGNG","LU2362540622.SGD","PQNT","BK4605","TINS","LU0384037296.USD","LU0072461881.USD","LU0985489474.SGD","LU0124676726.USD","SG9999015358.SGD","LU2089984988.USD","LU0878866978.SGD","LU0094547139.USD","LU2360032135.SGD","LU0359201885.HKD","LU0689626769.HKD","LU0316494557.USD","BK4213","LU0792757196.USD","LU1929549753.HKD","LU1282649067.USD","SG9999001424.SGD","LU2360106780.USD","LU0683600562.USD","HBMX","LU0456854461.SGD","LU2473716301.USD","IE0002270589.USD","LU2272731600.USD","IE00B5949003.HKD","LU0976567544.SGD","LU1508157978.USD","LU1582987324.SGD","SG9999014567.USD","LU2041044095.USD","LU2360108059.USD","LU0823421333.USD","LU2089985449.USD","LU1046421795.USD","LU0210536198.USD","LU2087621335.USD","IE00B7SZL793.SGD","LU0011850046.USD","LU2602419157.SGD","UDOW","LU2106854487.HKD","LU0264606111.USD","LU0553294199.USD","LU0068578508.USD","SG9999001440.SGD","OGIG","IE00BBT3K403.USD","IBBQ","IXC","LU1366192091.USD","LEGR","LU2294711713.HKD","LU0541501648.USD","LU1989771016.USD","LU0787776722.HKD","HYDR","LU2089283258.USD","TDIV","SG9999014575.USD","IE00B5TLWC47.USD","BGIA","IE00BJT1NW94.SGD","LU0648000940.SGD","LU1582986359.USD","LU0572939691.SGD","LU1934455277.USD","CGDG","FENI","CGGO","AIS","IE00BMPRXR70.SGD","LU2211814178.USD","LU0738911758.USD","PBE","LU2054465674.USD","LU0187121727.USD","EPAI","LU1734074674.USD","LU0300736492.USD","ESIM","LU0128525689.USD","IE00BQXX3D17.EUR","LU1935043023.USD","LU2543165471.USD","BK4141","LU0238689110.USD","WEEI","LU0109392836.USD","LU1069347547.HKD","LU2487616109.SGD","XLE","CNAV","LU1267930490.SGD","ORCU","NVS","SG9999015341.SGD","LU0081259029.USD","LU2322448791.USD","LU1023057109.AUD","IE00BFXG1179.USD","LU1691799644.USD","IE00BKDWB100.SGD","LU1732800096.USD","SG9999002232.USD","IE00BZ199S13.USD","LU1153585028.USD","LU0488056044.USD","LU0528227936.USD","LU2242646821.SGD","IE0004091025.USD","LU0823039010.USD","LU0965509010.AUD","LU1037948897.HKD","LU2247934214.USD","LU0477156953.USD","IE00BLSP4452.SGD","LU0149725797.USD","LU0070302665.USD","SPY","LU1935042488.USD","LU2125154778.USD","BAI","BK4515","LU0321505868.SGD","LU0097036916.USD","LU0143863198.USD","LU0868486357.SGD","SPWO","LU1430594728.SGD","BK4543","LU2237443382.USD","LU2290526834.HKD","LU0143863784.USD","LU1435385759.SGD","LU1894683348.USD","LU2236285917.USD","LU0130102774.USD","LU0612318385.USD","LU0345770308.USD","GXPE","LU0320765489.SGD","SGXZ51526630.SGD","IE00BYQQ9H92.USD","LU1974910355.USD","LU0154245673.USD","LU1582986433.USD","LU1074936037.SGD","FOTO","LU2237957811.SGD","LU0310800965.SGD","WUGI","EMM","03165","IE00B2B36J28.USD","BK5113","IE0004086264.USD","BK4578","GSID","FTXN","IE000F7OJYX1.SGD","LU0882574055.USD","BBH","LU0256331488.USD","LU1868837722.USD","IE0009355771.USD","LU0957808578.USD","LU2111349929.HKD","IE00B1XK9C88.USD","LU0154236417.USD","LU1989772840.SGD","IE000SO60NU8.SGD","LU0098860793.USD","LU2129689605.HKD","IE00B66KJ199.SGD","LU2506952170.USD","SGXZ81514606.USD","DDM","LU0950375773.USD","LU2896262040.SGD","LU0323591593.USD","LU0154245756.USD","LU0274383776.USD","LU2506951958.HKD","SG9999013999.USD","LU2357627491.SGD","LU1489326972.SGD","LU0353189680.USD","BK4581","LU0061474960.USD","LU0029874061.USD","LU1935043536.SGD","BK4566","LU2129689514.USD","IGV","LU1003077747.HKD","LU0431992006.USD","QTUP","LU0320765646.SGD","SGXZ57979304.SGD","LU0289960550.SGD","LU1791710582.SGD","IE00BN8TJ469.HKD","DXD","LU0466842654.USD","LU0345769128.USD","LU2133065610.SGD","LU2250418816.HKD","LU0198837287.USD","LU0266512127.USD","LU1718418525.SGD","LU1429558221.USD","BK4023","LU2592432038.USD","LU1934455863.HKD","LU1883866441.USD","LU1035773651.USD","TEXU","SG9999001176.SGD","LU0256863811.USD","LU0661504455.SGD","BK4608","LU2491050071.SGD","BK4157","INTC","LU1150488135.SGD","LU0234570918.USD","EMC","LU0122379950.USD","LU0345781412.USD","BK4527","LU1201861165.SGD","IE00B4R5TH58.HKD","IE00BD6J9T35.USD","LU0266512473.USD","LU0823414551.USD","LU0823417737.USD","LU2237443549.SGD","LU0278409577.USD","CTEX","BK7104","LU1935042215.USD","IE0000B7K699.USD","EFA","LU0251142724.SGD","LU2264538146.SGD","LINT","LU0368265418.SGD","LU2272731865.HKD","LU1803068979.SGD","LU2272731782.SGD","BK4534","LU0084288322.USD","BK4170","LU1712237335.SGD","LU1048588211.SGD","BK4559","LU0211331839.USD","LU0056508442.USD","IE00BSNM7G36.USD","LU2023251221.USD","LU2720916845.USD","LU2102340556.USD","HK0000304805.HKD","BIB","THNR","LU0878005551.USD","SG9999001176.USD","LU2244417387.USD","LU2112291526.USD","BK4548","LU0980610538.SGD","CRAK","LU1992135472.HKD","TRUN","LU2265009873.SGD","OZEM","LU1992135399.USD","LU0267386448.USD","IEO","LU0795875086.SGD","BK4148","IE0004445239.USD","LU0175139822.USD","LU1267930813.SGD","LU2360107168.USD","KNOW","LU1720051108.HKD","LU1582987597.SGD","IE00BMPRXQ63.HKD","LU0234572021.USD","LU1868838027.USD","LU2746668974.SGD","LU0251132253.USD","LU0211326839.USD","PXE","BK4585","IE00BFTCPJ56.SGD","IGE","SG9999003800.SGD","LU0052756011.USD","LU0823434583.USD","WQTM","LUMA","TNGY","LU0130103400.USD","LU0742534661.SGD","LU2860962120.EUR","ASIA","LU2362541273.HKD","LU1983299246.USD","LU2237443622.USD","IE00BKPKM429.USD","SDOW","ILOW","LU0889565833.HKD","IE000WAW04H5.SGD","LU0266013472.USD","LU2506951875.HKD","DBEU","LU0138981039.USD","LU0211327993.USD","LU1366333091.USD","CORO","IE00B1BXHZ80.USD","LU0965509101.SGD","TTEQ","IE00B19Z3B42.SGD","LU2242652126.USD","LU0210528500.USD","LU2458330243.SGD","LU2750360641.GBP","LU2063271972.USD","LU2458330169.SGD","BK4602","BLOX","SOXX","LU0630314457.HKD","IE00BGHQF524.EUR","IE00B3S45H60.SGD","IE00B19Z4B17.USD","LU0444973449.USD","LU0251131958.USD","LU0321505439.SGD","LU2750360997.AUD","BK4516","LU0048573561.USD","LU1066053197.SGD","LU0965508806.USD","HK0000304797.USD","LU0889565916.HKD","BK4554","AVSE","OILT","LU0048584097.USD","LU0823416689.USD","LU1023059063.AUD","LU2023250504.SGD","LU2506951792.HKD","LU2357305700.SGD","LU2954938101.SGD","DIG","SG9999000418.SGD","GNOM","LU1291159041.SGD","IE0002141913.USD","LU1585245621.USD","LU2089284900.SGD","LU1791710400.SGD","LU1894683264.USD","DIA","LU0162691827.USD","ASMH","LU1861215975.USD","IE00BWXC8680.SGD","LU1267930227.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665215326","title":"諾華試驗受挫且BMO下調評級,安進股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2665215326","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665215326?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:27","pubTimestamp":1788859661,"startTime":"0","endTime":"0","summary":"BUZZ-诺华试验受挫且BMO下调评级,安进股价下跌9月8日-** 安进公司(AMGN.O)股价盘前下跌4.8%,至416美元** 诺华公司(NOVN.S)的降胆固醇药物在一项备受关注的研究中未能达标,这引发了市场对安进公司(Amgen)实验性降胆固醇药物olpasiran的担忧 (link)** 摩根大通分析师表示,诺华的pelacarsen研究结果降低了市场对安进olpasiran的预期,而该","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nL4T4500MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU0058720904.USD","SG9999001440.SGD","BK4581","BK4588","IBBQ","LU0889565916.HKD","IE00BFTCPJ56.SGD","BIB","PBE","LU0109394709.USD","LU0122379950.USD","BK4139","LU0320765992.SGD","LU1983299246.USD","IE0009355771.USD","LU1057294990.SGD","BK4534","LU2112291526.USD","LU1023059063.AUD","IE00B2B36J28.USD","BK4533","LU2089984988.USD","BK4599","LU2242652126.USD","AMGN","BBH","LU1571399168.USD","IBB","IE00BJT1NW94.SGD","LU0289739699.SGD","IE0002141913.USD","LU2242646821.SGD","LU0868494617.USD","BK4566","LU2468319806.SGD","PJP","IE00B4R5TH58.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176595225","title":"盤前異動:安進、耐克、Bloom Energy 等個股受關注","url":"https://stock-news.laohu8.com/highlight/detail?id=1176595225","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176595225?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:10","pubTimestamp":1788858632,"startTime":"0","endTime":"0","summary":"安进:这家生物科技巨头、道琼斯指数的重要权重股,其盘前股价重挫逾5%。此前,瑞士制药商诺华宣称,其一款实验性药物在晚期临床试验中未能有效降低心血管风险。安进与礼来目前正在各自研发竞品疗法以应对挑战。消息传出后,诺华在欧股市场大跌10%,礼来股价亦小幅走低。Bloom Energy:这家燃料电池制造商可谓利好连连。受此提振,其盘前股价上扬4%。游戏驿站定于今日美股收盘后发布财报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","APED","BK4539","BK4566","BK4535","BK4182","BIB","BKCH","VCLN","BK4547","LU2264538146.SGD","HOOW","BK4595","SMI3.UK","LU0792757196.USD","BK4578","LU0310800965.SGD","LU1642822529.SGD","COIN","BK4596","LU2098885051.SGD","BEX","IBBQ","IE00B4R5TH58.HKD","IBAT","SMST","BK4533","BK4561","LU0823414551.USD","GMEC","IBLC","LU1861558580.USD","07799","LU0029864427.USD","LU1267930813.SGD","MSTW","STYL","CONL","SIMS","BK4541","IGME","LU2360107671.USD","MSTK","LU0058720904.USD","LU0823414478.USD","LU1303367103.USD","IE00B2B36J28.USD","WATS","09399","BITQ","CRPT","LU1023059063.AUD","LU1861217088.USD","LU1861220207.SGD","MSTR","EGGY","BK4585","LU0444971666.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","UPGR","CTEC","NVS","MSDD","BEG","3SMI.UK","LU0289739699.SGD","IE0009355771.USD","07711","BK4599","BPAY","LU1571399168.USD","SG9999001440.SGD","SMOG","MSTP","HOOG","LU2112291526.USD","FIAT","IBB","FDIG","BK4139","IMST","LU1983299246.USD","BK4146","COYY","LU0786609619.USD","BK4581","04332","COIO","BK4600","LU2089984988.USD","CONI","BK4558","WNTR","LU2294711713.HKD","CONX","BEC","LU1057294990.SGD","MSTX","LU0708994859.HKD","COIA","HOOD","LU2506951792.HKD","CONY","ICLN","MSOO","AMGN","BBH","ICOI","COIX","HOOZ","LU0957808578.USD","09799","GMEY","LU2468319806.SGD","ROBN","IE00BYQQ9H92.USD","COIW","BK4554","CNRG","BK4534","HOOI","BK4007","BK4076","GMEU","GME","LU0211331839.USD","BK4588","LU0109394709.USD","LU0128525689.USD","FRNW","LU2242646821.SGD","LU1267930227.SGD","LU0070302665.USD","HOOX","PBE","HOOC","07399","MSTY.UK","IE0009354923.USD","IE00BJT1NW94.SGD","3LMI.UK","07311","MSTZ","09311","LU1064131342.USD","TBXU","LU0052756011.USD","PJP","MST","LU2357125470.USD","LU0310800379.SGD","LU2242652126.USD","LU1267930573.SGD","BK4023","MSTC","LU0823411888.USD","MSST","LU2249611893.SGD","BEZ","09711","MSTU","LMI3.UK","VTWG","IAI","LU0320765489.SGD","HOOY","MSII","LU0476273544.USD","BK4551","COIG","IE0002141913.USD","LU0208291251.USD","HODU","HOYY","LU1061106388.HKD","LU0320765992.SGD","MEDX","ZAP","BK4112","LU2543165471.USD","MSTY","DAPP","LU0889565916.HKD","LU1988902786.USD","LU1815336760.USD","BLCK","NKE","IE00BFXG0V08.USD","LU0128525929.USD","LU0868494617.USD","COII","BK4127","FINX","BK4532","PPH","OWNB","LU0122379950.USD","LU0444973449.USD","MTYY","HOII","LU1861559042.SGD","BK4577","LU0889566641.SGD","BE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326953","title":"美股異動|安進盤前跌5.4%,諾華同靶點藥物III期臨床失敗,Lp(a)賽道遭重創","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326953","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665326953?lang=zh_tw&edition=fundamental","pubTime":"2026-09-08 17:07","pubTimestamp":1788858422,"startTime":"0","endTime":"0","summary":"消息面上,诺华于9月4日公布,其与Ionis联合开发的降脂药物Pelacarsen,在名为LpHORIZON的III期临床试验中未能达到主要终点。诺华的Pelacarsen是全球首个针对Lp靶点进行心血管结局验证的III期药物。因此,市场担忧情绪蔓延到了同样在开发Lp药物的安进身上。多家分析机构认为,诺华的失败削弱了但并未完全推翻Lp这一靶点的可行性。安进后续公布的Olpasiran完整试验数据,将成为判断该靶点未来走向的关键。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260908/32363493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK4599","BK4139","BK4566","LU0058720904.USD","BK4532","IE00BFTCPJ56.SGD","LU2112291526.USD","AMGN","BK4588","BK4585","LU1983299246.USD","BBH","LU0109394709.USD","PPH","PJP","LU2468319806.SGD","IE0002141913.USD","LU1023059063.AUD","IE00BJJMRZ35.SGD","TBXU","LU0070302665.USD","LU0868494617.USD","BK4534","MEDX","PBE","LU2242652126.USD","IBB","LU0208291251.USD","LU0320765489.SGD","LU1057294990.SGD","BK4007","IBBQ","IE00B4R5TH58.HKD","BK4581","LU2089984988.USD","BK4578","LU0122379950.USD","IE0009355771.USD","BK4533","LU0889565916.HKD","LU0320765992.SGD","LU0211331839.USD","BIB","SG9999001440.SGD","NVS","LU0289739699.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1061106388.HKD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":198,"code":"91000000","status":"200"}]}}